Jae Wha Kim

Dr. Jae Wha Kim

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2004 in The Breast
Verified
Journal Article
Closed access
JKJoo Heon Kim
Joo Heon Kim
SYSun Young Yoon
Sun Young Yoon
SJSeong-Hoo Jeong
Seong-Hoo Jeong
SKSoo Young Kim
Soo Young Kim
SMSang Kyoung Moon
Sang Kyoung Moon
JKJae Wha Kim
Jae Wha Kim

14 September 2004 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
UHUn-Hwan Ha
Un-Hwan Ha
JKJae Wha Kim
Jae Wha Kim
HBHassan Badrane
Hassan Badrane
JJJinghua Jia
Jinghua Jia
HBHenry V. Baker
Henry V. Baker
SJShouguang Jin
Shouguang Jin
Summary: We have previously reported on the isolation of in vivo inducible genes of Pseudomonas aeruginosa using IVET system. One of such genes isolated from burn mouse infection model encodes a short open reading frame with unknown function. In this study, we demonstrate that this gene product specifically suppresses the expression of type III secretion genes in P. aeruginosa, thus named PtrA (Pseudomonas type III repressor A). A direct interaction between the PtrA and type III transcriptional activator ExsA was demonstrated, suggesting that its repressor function is probably realized through inhibition of the ExsA protein function. Indeed, an elevated expression of the exsA compensates the repressor effect of the PtrA. Interestingly, expression of the ptrA is highly and specifically induced by copper cation. A copper‐ responsive two‐component regulatory system, copR‐copS, has also been identified and shown to be essential for the copper resistance in P. aeruginosa as well as the activation of ptrA in response to the copper signal. Elevated expression of the ptrA during the infection of mouse burn wound suggests that P. aeruginosa has evolved tight regulatory systems to shut down energy‐expensive type III secretion apparatus in response to specific environmental signals, such as copper stress.

1 December 2004 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SYSun Young Yoon
Sun Young Yoon
YLYounghee Lee
Younghee Lee
JKJoo Heon Kim
Joo Heon Kim
ACAn-Sik Chung
An-Sik Chung
JJJoung Hyuck Joo
Joung Hyuck Joo
JKJae Wha Kim
Jae Wha Kim

1 April 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JHJungwon Hwang
Jungwon Hwang
YKYoonjeong Kim
Yoonjeong Kim
HKHo Bum Kang
Ho Bum Kang
LJLukasz Jaroszewski
Lukasz Jaroszewski
ADAshley M. Deacon
Ashley M. Deacon
Myunghee KimMyunghee Kim
Myunghee Kim
Considerable attention has recently been paid to the N-Myc downstream-regulated gene (NDRG) family because of its potential as a tumor suppressor in many human cancers. Primary amino acid sequence information suggests that the NDRG family proteins may belong to the α/β-hydrolase (ABH) superfamily; however, their functional role has not yet been determined. Here, we present the crystal structures of the human and mouse NDRG2 proteins determined at 2.0 and 1.7 Å resolution, respectively. Both NDRG2 proteins show remarkable structural similarity to the ABH superfamily, despite limited sequence similarity. Structural analysis suggests that NDRG2 is a nonenzymatic member of the ABH superfamily, because it lacks the catalytic signature residues and has an occluded substrate-binding site. Several conserved structural features suggest NDRG may be involved in molecular interactions. Mutagenesis data based on the structural analysis support a crucial role for helix α6 in the suppression of TCF/β-catenin signaling in the tumorigenesis of human colorectal cancer, via a molecular interaction.

1 November 2005 in Microbiology
Verified
Journal Article
Open access
PDF file
JKJae Wha Kim
Jae Wha Kim
KAKyungseop Ahn
Kyungseop Ahn
SMSungran Min
Sungran Min
JJJinghua Jia
Jinghua Jia
UHUn-Hwan Ha
Un-Hwan Ha
SJShouguang Jin
Shouguang Jin
The type III secretion system ofPseudomonas aeruginosais tightly regulated by various environmental signals, such as low calcium and contact with the host cell. However, the exact signals triggering type III secretion are unknown. The present study describes the finding that secretion ofP. aeruginosatype III effector molecules requires protein factors from serum and L broth, designated type III secretion factors (TSFs), in addition to the low-calcium environment. In the absence of TSF or calcium chelator EGTA, basal levels of type III effector molecules are accumulated intracellularly. Addition of TSF and EGTA together effectively triggers the secretion of pre-existing effector molecules in a short time, even before the active expression of type III genes; thus, active type III gene expression does not seem to be a prerequisite for type III secretion. A search for TSF molecules in serum and L broth resulted in the identification of albumin and casein as the functional TSF molecules. Although there is no clear sequence similarity between albumin and casein, both proteins are known to have a low-affinity, high-capacity calcium-binding property. Tests of well-studied calcium-binding proteins seemed to indicate that low-affinity calcium-binding proteins have TSF activity, although the requirement of low-affinity calcium-binding ability for the TSF activity is not clear.P. aeruginosaseems to have evolved a sensing mechanism to detect target cells for type III injection through host-derived proteins in combination with a low-calcium signal. Disruption of the bacterial ability to sense low calcium or TSF might be a valid avenue to the effective control of this bacterial pathogen.

9 October 2008 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
YKYoung Jun Kim
Young Jun Kim
SYSun Young Yoon
Sun Young Yoon
JKJong‐Tae Kim
Jong‐Tae Kim
SCSeung Cheol Choi
Seung Cheol Choi
Jong-Seok LimJong-Seok Lim
Jong-Seok Lim
JKJae Wha Kim
Jae Wha Kim
Recently, the anti‐tumor activity of N‐myc downstream‐regulated gene 2 (NDRG2) was elucidated, but the molecular mechanism of how NDRG2 works as a tumor suppressor is not well known. To determine the function of NDRG2 as a tumor suppressor, we established stable cell lines expressing NDRG2 protein or its mutant forms, and studied their effects on tumor cell growth. Interestingly, constitutive expression of wild‐type NDRG2 induced the growth retardation of SW620 colon carcinoma cells. Introduction of NDRG2 into SW620 cells induced the decrease of c‐Jun phosphorylation at Ser63, followed by the attenuation of activator protein‐1 (AP‐1) function as a transcriptional activator. Subsequently, the down‐regulation of cyclin D1, which is known as a major target for AP‐1 transcription activator, resulted in cell cycle arrest at G1/S phase. Additionally, treatment of NDRG2‐siRNA on NDRG2‐expressing cells has induced the recovery of c‐Jun phosphorylation and cyclin D1 expression. Cell proliferation of those cells was also increased compared with untreated cells. NDRG2 mutants of which the phosphorylation sites at C‐terminal region were removed by deletion or site‐directed mutagenesis have shown no effect on cyclin D1 expression and could not induce cell growth retardation. In conclusion, NDRG2 modulates intracellular signals to control cell cycle through the regulation of cyclin D1 expression via phosphorylation pathway.